Skip to main content
. 2020 Jan 1;16(4):568–582. doi: 10.7150/ijbs.39769

Table 1.

B7 family's mRNA expression and clinicopathological Characteristics of gastric cancer patients in the TCGA database.

Characteristics B7
High Low χ2 P High Low χ2 P High Low χ2 P
OS status B7-1 B7-2 B7-DC
Dead 112 117 0.3565 0.5505 111 118 0.6557 0.4181 106 123 3.509 0.0610
Alive 75 69 76 68 81 63
B7-H1 B7-H2 B7-H3
Dead 114 115 0.02946 0.8637 117 112 0.2176 0.6409 106 123 3.509 0.0610
Alive 73 71 70 74 81 63
B7-H4 B7-H5 B7-H6
Dead 121 108 1.735 0.1877 115 114 0.001686 0.9672 117 112 0.2176 0.6409
Alive 66 78 72 72 70 74
B7-H7
Dead 112 117 0.3565 0.5505
Alive 75 69
Gender B7-1 B7-2 B7-DC
Male 72 61 1.324 0.2499 67 66 0.0215 0.8834 70 63 0.5157 0.4727
Female 115 125 119 121 117 123
B7-H1 B7-H2 B7-H3
Male 73 60 1.868 0.1717 70 63 0.5157 0.4727 65 68 0.1317 0.7167
Female 114 126 117 123 122 118
B7-H4 B7-H5 B7-H6
Male 60 73 30.81 <0.0001 66 67 0.0215 0.8834 71 62 0.873 0.3501
Female 127 113 121 119 116 124
B7-H7
Male 63 70 0.6324 0.4265
Female 124 116
Cancer status B7-1 B7-2 B7-DC
Normal 59 61 0.07221 0.7881 61 59 0.035 0.8516 63 57 0.4133 0.5203
Tumor 109 106 107 108 105 110
B7-H1 B7-H2 B7-H3
Normal 57 63 0.5249 0.4687 59 61 0.07221 0.7881 65 55 1.207 0.2719
With Tumor 111 104 109 106 103 112
B7-H4 B7-H5 B7-H6
Normal 63 57 0.4133 0.5203 66 54 1.76 0.1846 53 67 2.677 0.1018
Tumor 105 110 102 113 115 100
B7-H7
Normal 58 62 0.2466 0.6195
Tumor 110 105
Grade B7-1 B7-2 B7-DC
G1 4 6 5.088 0.0786 5 5 24.25 <0.0001 4 6 23.34 <0.0001
G2 58 77 45 90 46 89
G3 120 99 132 87 132 87
B7-H1 B7-H2 B7-H3
G1 4 6 6.082 0.0478 6 4 0.6263 0.7311 5 5 0.9699 0.6157
G2 57 78 65 70 63 72
G3 121 98 111 108 114 105
B7-H4 B7-H5 B7-H6
G1 6 4 11.02 0.0041 4 6 4.189 0.1231 7 3 11.39 0.0034
G2 82 53 59 76 81 54
G3 94 125 119 100 94 125
B7-H7
G1 7 3 7.721 0.0211
G2 78 57
G3 97 122
Race B7-1 B7-2 B7-DC
Asian 34 40 3.366 0.1858 36 38 4.929 0.0850 33 41 9.598 0.0082
White 124 112 123 113 127 109
Others 3 8 2 9 1 10
B7-H1 B7-H2 B7-H3
Asian 31 43 3.846 0.1462 53 21 17.74 0.0001 29 45 5.105 0.0779
White 126 110 103 133 125 111
Others 4 7 5 6 7 4
B7-H4 B7-H5 B7-H6
Asian 36 38 0.8691 0.6475 40 34 4.955 0.0840 35 39 2.486 0.2885
White 118 118 119 117 118 118
Others 7 4 2 9 8 .3
B7-H7
Asian 34 40 2.773 0.2499
White 119 117
Others 8 3
Pathologic stage B7-1 B7-2 B7-DC
Stage I 21 32 3.886 0.2741 18 35 6.466 0.0910 18 35 7.912 0.0479
Stage II 53 58 59 52 55 56
Stage III 81 68 78 71 84 65
Stage IV 20 17 20 17 18 19
B7-H1 B7-H2 B7-H3
Stage I 27 26 1.104 0.7760 17 36 8.69 0.0337 26 27 2.38 0.4973
Stage II 51 60 62 49 58 53
Stage III 78 71 78 71 69 80
Stage IV 19 18 18 19 22 15
B7-H4 B7-H5 B7-H6
Stage I 32 21 6.208 0.1019 23 30 1.237 0.7441 26 27 7.085 0.0692
Stage II 61 50 58 53 46 65
Stage III 67 82 76 73 79 70
Stage IV 15 22 18 19 24 13
B7-H7
Stage I 27 26 0.1337 0.9875
Stage II 54 57
Stage III 75 74
Stage IV 19 18
Tumor topography B7-1 B7-2 B7-DC
T1 5 14 7.035 0.0708 2 17 14.69 0.0021 4 15 12.11 0.0070
T2 40 40 42 38 41 39
T3 81 87 82 86 78 90
T4 58 42 58 42 61 39
B7-H1 B7-H2 B7-H3
T1 5 14 8.817 0.0310 10 9 9.414 0.0243 5 14 4.774 0.1891
T2 47 33 28 52 43 37
T3 77 91 92 76 85 83
T4 55 45 54 46 51 49
B7-H4 B7-H5 B7-H6
T1 14 5 10.4 0.0154 10 9 0.3051 0.9591 11 8 9.005 0.0292
T2 48 32 40 40 35 45
T3 80 88 86 82 76 92
T4 42 58 48 52 62 38
B7-H7
T1 11 8 1.092 0.7790
T2 42 38
T3 80 88
T4 51 49
Lymph Node B7-1 B7-2 B7-DC
N1 51 62 3 0.3916 53 60 2.471 0.4805 49 64 3.196 0.3624
N2 54 42 54 42 52 44
N3 35 39 34 40 38 36
N4 39 35 38 36 40 34
B7-H1 B7-H2 B7-H3
N1 55 58 1.47 0.6892 56 57 2.264 0.5195 62 51 1.984 0.5758
N2 49 47 47 49 45 51
N3 41 33 42 32 38 36
N4 34 40 33 41 34 40
B7-H4 B7-H5 B7-H6
N1 57 56 5.578 0.1340 49 64 3.087 0.3783 55 58 1.825 0.6096
N2 46 50 52 44 44 52
N3 45 29 39 35 39 35
N4 31 43 39 35 41 33
B7-H7
N1 57 56 1.213 0.7498
N2 44 52
N3 40 34
N4 38 36